[Prevention of meningococcal meningitis]

Related Experiment Video

Updated: Oct 17, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

S Kastenbauer1, B Grabein, H W Pfister

  • 1Neurologische Klinik, Klinikum Grosshadern, München.

Der Nervenarzt
|March 7, 2000
PubMed

Insights

Meningococcal disease in Germany affects about 1 in 100,000 people, primarily children. Prompt antibiotic treatment and chemoprophylaxis are crucial for managing cases and preventing outbreaks.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Context:

  • Meningococcal disease incidence in Germany is stable at approximately 1/100,000.
  • Transmission primarily occurs via respiratory droplets from asymptomatic carriers.
  • Disease incidence peaks in children and declines with age.

Purpose:

  • To summarize key epidemiological features of meningococcal disease in Germany.
  • To outline current recommendations for clinical management and public health response.
  • To highlight strategies for outbreak control.

Summary:

  • The incubation period for meningococcal disease is typically 3-4 days (2-10 days range).
  • Mortality associated with meningococcal disease is around 10%.
  • Immediate antibiotic treatment (penicillin G or cephalosporin) is vital for suspected cases, followed by 24-hour isolation.

Impact:

  • Rapid reporting of suspected cases to public health authorities aids early outbreak detection.
  • Antimicrobial chemoprophylaxis (e.g., rifampin, ciprofloxacin, ceftriaxone) is recommended for close contacts.
  • Meningococcal vaccines are effective for controlling serogroup C outbreaks.

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...